Olga S. Anikina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olga S. Anikina has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Aleksey N. Arkhipov
Meshalkin National Medical Research Center
4 shared publications - Ilya A. Velyukhanov
Meshalkin National Medical Research Center
4 shared publications - Ilya Alexandrovich Soynov
Meshalkin National Medical Research Center
4 shared publications - Yuriy Yurievich Kulyabin
Meshalkin National Medical Research Center
4 shared publications - Ekaterina N. Amansakhatova
Meshalkin National Medical Research Center
3 shared publications - Igor Anatolyevich Kornilov
Milton S. Hershey Medical Center, Penn State University College of Medicine
3 shared publications
Latest Publications
- Open Access
- 14 April 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 30 (1) , 90-98
Ten years of experience with total perfusion for cerebral and end-organ protection during aortic arch reconstruction in neonates
Introduction. Whole-body perfusion represents a promising alternative to traditional methods, such as deep hypothermic circulatory arrest and antegrade cerebral perfusion, potentially reducing the risks of both neurological complications and acute kidney injury. However, the experience with its application, especially in the most vulnerable group of neonates, remains insufficiently studied and requires systematic analysis of intraoperative and longterm outcomes. Objective. To evaluate intraoperative and early postoperative outcomes in neonates undergoing aortic arch reconstruction with whole-body perfusion. Methods. This prospective cohort study evaluated the efficacy and safety of surgical treatment in neonates undergoing aortic arch reconstruction with total perfusion (n = 43). The median patient age was 8 (IQR 5–28) days, and median body weight was 3.4 (IQR 2.9–4) kg. Male patients predominated 25 (58.2 %). Results. The primary endpoint was acute kidney injury assessed using the pediatric KDIGO criteria. Acute kidney injury was observed in 9 (21 %) of patients. The only significant factor for acute kidney injury was the inotropic index on postoperative day 1 (OR = 1.08; 95 % CI (1.01; 1.17)). Neurological complications occurred in 4 (9.3 %) of patients. Hospital mortality was 1 (2.3 %). Conclusion. Whole-body perfusion represents a straightforward, efficacious, and safe organ protection strategy for neonatal aortic arch reconstruction, demonstrating a low rate of acute kidney injury.
- 14 April 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 30 (1) , 90-98
Open AccessTen years of experience with total perfusion for cerebral and end-organ protection during aortic arch reconstruction in neonates
Introduction. Whole-body perfusion represents a promising alternative to traditional methods, such as deep hypothermic circulatory arrest and antegrade cerebral perfusion, potentially reducing the risks of both neurological complications and acute kidney injury. However, the experience with its application, especially in the most vulnerable group of neonates, remains insufficiently studied and requires systematic analysis of intraoperative and longterm outcomes. Objective. To evaluate intraoperative and early postoperative outcomes in neonates undergoing aortic arch reconstruction with whole-body perfusion. Methods. This prospective cohort study evaluated the efficacy and safety of surgical treatment in neonates undergoing aortic arch reconstruction with total perfusion (n = 43). The median patient age was 8 (IQR 5–28) days, and median body weight was 3.4 (IQR 2.9–4) kg. Male patients predominated 25 (58.2 %). Results. The primary endpoint was acute kidney injury assessed using the pediatric KDIGO criteria. Acute kidney injury was observed in 9 (21 %) of patients. The only significant factor for acute kidney injury was the inotropic index on postoperative day 1 (OR = 1.08; 95 % CI (1.01; 1.17)). Neurological complications occurred in 4 (9.3 %) of patients. Hospital mortality was 1 (2.3 %). Conclusion. Whole-body perfusion represents a straightforward, efficacious, and safe organ protection strategy for neonatal aortic arch reconstruction, demonstrating a low rate of acute kidney injury.
- Open Access
- 2 March 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (1) , 109-125
THE 1st STAGE OF HEMODYNAMIC STRATEGIES FOR MANAGEMENT OF HYPOPLASTIC LEFT HEART SYNDROME
Highlights The research presented in this paper evaluates the alternatives for the 1 st stage of hemodynamic correction of HLHS, outlines possible complications that may emerge in the postoperative phase, and provides approaches for their overcome in the intraoperative period. Abstract Hypoplastic left heart syndrome (HLHS) is a congenital heart disease that describes in the underdevelopment of the left-sided structures of the heart. HLHS is a rare defect in infants born and occurs in 2–3% of all congenital heart diseases. Primary heart transplantation demonstrates a radical correction of HLHS. However, a shortage of organs and a prohibition on this procedure to juvenile make it unavailable. Therefore, this review presents options for surgical correction of newborns with hypoplastic left heart syndrome, their advantages and disadvantages, as well as possible complications.
- 2 March 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (1) , 109-125
Open AccessTHE 1st STAGE OF HEMODYNAMIC STRATEGIES FOR MANAGEMENT OF HYPOPLASTIC LEFT HEART SYNDROME
Highlights The research presented in this paper evaluates the alternatives for the 1 st stage of hemodynamic correction of HLHS, outlines possible complications that may emerge in the postoperative phase, and provides approaches for their overcome in the intraoperative period. Abstract Hypoplastic left heart syndrome (HLHS) is a congenital heart disease that describes in the underdevelopment of the left-sided structures of the heart. HLHS is a rare defect in infants born and occurs in 2–3% of all congenital heart diseases. Primary heart transplantation demonstrates a radical correction of HLHS. However, a shortage of organs and a prohibition on this procedure to juvenile make it unavailable. Therefore, this review presents options for surgical correction of newborns with hypoplastic left heart syndrome, their advantages and disadvantages, as well as possible complications.
- Open Access
- 20 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (5) , 108-113
Extracorporeal support for right ventricular failure following LVAD implantation in a 5-year-old child: a case report
Introduction. Postoperative right ventricular failure is a dangerous adverse event in patients after left ventricular assist device (LVAD) implantation. The survival rate of such patients is extremely low. The only strategy that enables patient survival after LVAD implantation is the use of extracorporeal membrane oxygenation (ECMO) to bypass the right ventricle. The objective was to present a case report on the management of right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation in a 5-year-old child, utilizing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy. Results. Serial echocardiographic assessment under ECMO support revealed progressive RV functional recovery, with FAC increasing from 7% to 28% and TR decreasing from 50% to 15% by postoperative day 10. The patient was successfully weaned from ECMO on day 14 with preserved RV function (FAC 30%, grade 1 TR). Conclusion. The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy provides hemodynamic stabilization, improves oxygenation, and creates optimal conditions for myocardial recovery. This case report demonstrates the efficacy of a gradual ECMO weaning protocol under echocardiographic guidance, which may prove valuable in managing similar clinical scenarios.
- 20 October 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (5) , 108-113
Open AccessExtracorporeal support for right ventricular failure following LVAD implantation in a 5-year-old child: a case report
Introduction. Postoperative right ventricular failure is a dangerous adverse event in patients after left ventricular assist device (LVAD) implantation. The survival rate of such patients is extremely low. The only strategy that enables patient survival after LVAD implantation is the use of extracorporeal membrane oxygenation (ECMO) to bypass the right ventricle. The objective was to present a case report on the management of right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation in a 5-year-old child, utilizing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy. Results. Serial echocardiographic assessment under ECMO support revealed progressive RV functional recovery, with FAC increasing from 7% to 28% and TR decreasing from 50% to 15% by postoperative day 10. The patient was successfully weaned from ECMO on day 14 with preserved RV function (FAC 30%, grade 1 TR). Conclusion. The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy provides hemodynamic stabilization, improves oxygenation, and creates optimal conditions for myocardial recovery. This case report demonstrates the efficacy of a gradual ECMO weaning protocol under echocardiographic guidance, which may prove valuable in managing similar clinical scenarios.
- Open Access
- 1 October 2024
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 20 (5) , 77-80
The Effect of Extracorporeal Membrane Oxygenation in the Management of Refractory Ventricular Tachycardia Developed after Fontan Procedure (Case Report)
Aim: to evaluate the effect of extracorporeal membrane oxygenation (ECMO) as a life support in the treatment of a patient with refractory ventricular tachycardia developed after Fontan procedure. Patient and treatment. A 4-year-old child developed refractory ventricular tachycardia (up to 250 bpm) and hemodynamic depression 18 hours after the Fontan procedure. After the failure of cardiopulmonary resuscitation and antiarrhythmic therapy, resternotomy with central venoarterial (VA) ECMO support was performed, followed by diagnostic angiocardiography. Contrast-enhanced cavopulmonary angiography revealed stenosis of the left pulmonary artery, which was treated with balloon angioplasty and stenting.Results. Ventricular tachycardia resolved and sinus rhythm was restored within 24 hours after left pulmonary artery stenting, supported by continuous ECMO and antiarrhythmic therapy. On day 3, transthoracic echocardiography showed good single ventricle contractility after a trial weaning from ECMO. As a result, the ECMO support was removed and the sternum sutured. The patient was discharged from the hospital on day 47 in stable condition.Conclusion. The prompt initiation of VA ECMO support in a 4-year old patient with refractory ventricular tachycardia post-Fontan procedure along with the complex management of post-procedural residual tachycardia using a combination of antiarrhythmic agents helped restoring sinus rhythm and could contribute to preventing neurological complications.
- 1 October 2024
- Published by FSBI SRIGR RAMS in General Reanimatology
- Vol. 20 (5) , 77-80
Open AccessThe Effect of Extracorporeal Membrane Oxygenation in the Management of Refractory Ventricular Tachycardia Developed after Fontan Procedure (Case Report)
Aim: to evaluate the effect of extracorporeal membrane oxygenation (ECMO) as a life support in the treatment of a patient with refractory ventricular tachycardia developed after Fontan procedure. Patient and treatment. A 4-year-old child developed refractory ventricular tachycardia (up to 250 bpm) and hemodynamic depression 18 hours after the Fontan procedure. After the failure of cardiopulmonary resuscitation and antiarrhythmic therapy, resternotomy with central venoarterial (VA) ECMO support was performed, followed by diagnostic angiocardiography. Contrast-enhanced cavopulmonary angiography revealed stenosis of the left pulmonary artery, which was treated with balloon angioplasty and stenting.Results. Ventricular tachycardia resolved and sinus rhythm was restored within 24 hours after left pulmonary artery stenting, supported by continuous ECMO and antiarrhythmic therapy. On day 3, transthoracic echocardiography showed good single ventricle contractility after a trial weaning from ECMO. As a result, the ECMO support was removed and the sternum sutured. The patient was discharged from the hospital on day 47 in stable condition.Conclusion. The prompt initiation of VA ECMO support in a 4-year old patient with refractory ventricular tachycardia post-Fontan procedure along with the complex management of post-procedural residual tachycardia using a combination of antiarrhythmic agents helped restoring sinus rhythm and could contribute to preventing neurological complications.